INHIBITION OF THROMBIN AND OTHER TRYPSIN-LIKE SERINE PROTEINASES BY CYCLOTHEONAMIDE-A

被引:59
作者
LEWIS, SD
NG, AS
BALDWIN, JJ
FUSETANI, N
NAYLOR, AM
SHAFER, JA
机构
[1] MERCK SHARP & DOHME LTD, DEPT BIOL CHEM, 16-101, West Point, PA 19486 USA
[2] MERCK SHARP & DOHME LTD, DEPT MED CHEM, West Point, PA 19486 USA
[3] MERCK SHARP & DOHME LTD, DEPT MOLEC SYST, West Point, PA 19486 USA
[4] UNIV TOKYO, MARINE BIOCHEM LAB, BUNKYO KU, TOKYO 113, JAPAN
关键词
FACTOR-XA; TISSUE PLASMINOGEN ACTIVATOR; PLASMIN; ANTITHROMBIN-III;
D O I
10.1016/0049-3848(93)90158-K
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cyclotheonamide A (CA), a cyclic peptide isolated from the marine sponge of the genus Theonella was shown to be a slow-binding inhibitor of several trypsin-like serine proteinases. Values of 4.6x10(4), 4.8x10(4), 9.3x10(3), 2.1x10(3) and 2.7x10(2) M-1 s-1 were determined for the second-order rate constants for formation of CA complexes with thrombin, trypsin, plasmin, 2-chain t-PA and factor Xa, respectively. The equilibrium constant (K(i)) was measured for dissociation of CA from the CA complex with human thrombin (K(i)=1.0 nM), bovine trypsin (K(i)=0.2 nM), human plasmin (K(i)=12 nM), human factor Xa (K(i)=50 nM) and human 2-chain tissue plasminogen activator (t-PA) (K(i)=40 nM). CA produces dose dependent increases in clotting time assays. The clotting time in the thrombin time, activated partial thromboplastin time and prothrombin time assays, were doubled by 1.5, 0.9 and 48 muM CA, respectively. A model for the binding of CA to the active site of thrombin is proposed.
引用
收藏
页码:173 / 190
页数:18
相关论文
共 24 条
[1]  
BANNER DW, 1991, J BIOL CHEM, V266, P20085
[2]   HYDRODYNAMIC STUDIES ON THE STREPTOKINASE COMPLEXES OF HUMAN-PLASMINOGEN, VAL442-PLASMINOGEN, PLASMIN, AND THE PLASMIN-DERIVED LIGHT (B) CHAIN [J].
BARLOW, GH ;
SUMMARIA, L ;
ROBBINS, KC .
BIOCHEMISTRY, 1984, 23 (11) :2384-2387
[3]   ISOLATION OF HUMAN-BLOOD COAGULATION ALPHA-FACTOR-XA BY SOYBEAN TRYPSIN-INHIBITOR SEPHAROSE CHROMATOGRAPHY AND ITS ACTIVE-SITE TITRATION WITH FLUORESCEIN MONO-P-GUANIDINOBENZOATE [J].
BOCK, PE ;
CRAIG, PA ;
OLSON, ST ;
SINGH, P .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1989, 273 (02) :375-388
[4]   THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT [J].
BODE, W ;
MAYR, I ;
BAUMANN, U ;
HUBER, R ;
STONE, SR ;
HOFSTEENGE, J .
EMBO JOURNAL, 1989, 8 (11) :3467-3475
[5]   TIGHT-BINDING INHIBITORS .1. KINETIC-BEHAVIOR [J].
CHA, S .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (23) :2177-2185
[6]  
DAVIE EW, 1955, J BIOL CHEM, V212, P515
[7]  
DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022
[8]  
EVANS SA, 1982, J BIOL CHEM, V257, P3014
[9]  
FENTON JW, 1977, J BIOL CHEM, V252, P3587
[10]   BIOACTIVE MARINE METABOLITES .33. CYCLOTHEONAMIDES, POTENT THROMBIN INHIBITORS, FROM A MARINE SPONGE THEONELLA SP [J].
FUSETANI, N ;
MATSUNAGA, S ;
MATSUMOTO, H ;
TAKEBAYASHI, Y .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (19) :7053-7054